SPHERA FUNDS MANAGEMENT LTD.
Top Portfolio Positions
91 positions ·
$591,353,809 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
1,339,971 | $36,299,814 | 6.14% | |
| TEVA |
Teva Pharmaceutical Industries Ltd
Healthcare
|
1,136,975 | $34,245,687 | 5.79% | |
| TSEM |
Tower Semiconductor Ltd
Technology
|
145,735 | $25,573,577 | 4.32% | |
| NVMI |
Nova Ltd.
Technology
|
53,366 | $23,175,786 | 3.92% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
299,117 | $19,714,801 | 3.33% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
245,246 | $18,211,967 | 3.08% | |
| BIIB |
Biogen Inc.
Healthcare
|
92,526 | $16,962,791 | 2.87% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
809,333 | $16,955,526 | 2.87% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
724,563 | $16,925,791 | 2.86% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
416,340 | $16,024,926 | 2.71% |
Portfolio Trend
25 quarters · across all stocks
Holdings in FOLD
Shares Held
Position Value (USD)
10 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,724,831 | 603,377 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,375,288 | 658,377 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,810,198 | 991,142 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,676,814 | 990,718 | Shares | Defined | 2025-08-14 | |
| 2022-06-30 | $8,087,617 | 753,037 | Shares | Defined | 2022-08-15 | |
| 2021-09-30 | $4,690,568 | 491,159 | Shares | Defined | 2021-11-15 | |
| 2020-12-31 | $6,136,236 | 265,753 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $17,558,926 | 1,243,550 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $24,558,534 | 1,628,550 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $18,642,845 | 2,017,624 | Shares | Defined | 2020-05-14 | |
| No 13F history on record for this holder in this stock. | ||||||